| Title |
Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
|
|---|---|
| Published in |
Advances in Therapy, August 2019
|
| DOI | 10.1007/s12325-019-01052-y |
| Pubmed ID | |
| Authors |
Marilyn K. Glassberg, Steven D. Nathan, Chin-Yu Lin, Elizabeth A. Morgenthien, John L. Stauffer, Willis Chou, Paul W. Noble |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | 25% |
| United States | 1 | 25% |
| United Kingdom | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 50% |
| Science communicators (journalists, bloggers, editors) | 2 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 77 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 12 | 16% |
| Student > Postgraduate | 6 | 8% |
| Student > Master | 5 | 6% |
| Student > Ph. D. Student | 5 | 6% |
| Student > Doctoral Student | 4 | 5% |
| Other | 5 | 6% |
| Unknown | 40 | 52% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 18 | 23% |
| Nursing and Health Professions | 11 | 14% |
| Biochemistry, Genetics and Molecular Biology | 2 | 3% |
| Engineering | 2 | 3% |
| Sports and Recreations | 2 | 3% |
| Other | 3 | 4% |
| Unknown | 39 | 51% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 June 2021.
All research outputs
#2,163,959
of 23,153,849 outputs
Outputs from Advances in Therapy
#175
of 2,388 outputs
Outputs of similar age
#46,947
of 344,344 outputs
Outputs of similar age from Advances in Therapy
#6
of 62 outputs
Altmetric has tracked 23,153,849 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,388 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,344 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.